Results 211 to 220 of about 129,523 (248)

Randomised, double-masked trial to compare the efficacy, safety and immunogenicity of the biosimilar aflibercept FYB203 with reference aflibercept in patients with neovascular age-related macular degeneration. [PDF]

BMJ Open Ophthalmol
Balser S, Capsius B, Hole R, Papp A, Preissinger N, Rozenknop A, Tiko T.   +6 more
europepmc   +1 more source

Scalable and Privacy-Conscious End-to-End Processing of Large-Scale Clinical Data for Precision Medicine: Empirical Evaluation Study.

JMIR Med Inform
Lee J, Hwang S, Lee KH.
europepmc   +1 more source

Talazoparib Formulation Bridging in Cancer Patients-Challenges and the Critical Role of Model-Informed Drug Development in Approval Despite Failed Bioequivalence. [PDF]

CPT Pharmacometrics Syst Pharmacol
Wang D, Guo CC, Gao X, Wang Y, Yu Y, Plotka A, Elmeliegy M, Shi H, Johnson S, DeAnnuntis L, Hoffman J.   +10 more
europepmc   +1 more source

Feedback-driven event-related potentials in conditional discrimination: insights from a matching-to-sample study. [PDF]

Front Hum Neurosci
Edmunds KJ, Chu MY, Arntzen E, Gargiulo P, Steingrimsdottir HS.   +4 more
europepmc   +1 more source

Pre-appraisal commentary on the PARTNER 3 seven-year results: The wrong button at the top. [PDF]

Turk Gogus Kalp Damar Cerrahisi Derg
Çiçek S.
europepmc   +1 more source

Association between reduced chewing-induced brain blood flow and cognitive performance in mandibular prognathism patients in a pilot study. [PDF]

Sci Rep
Inagawa Y, Kanzaki H, Kariya C, Tanaka S, Kumazawa M, Tomonari H.   +5 more
europepmc   +1 more source